ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Concalls
Every earnings call, live and summarised
Earnings calls
Every Apollo Hospitals Enterprise earnings call we streamed: the live audio and our summary of what management said.
Consolidated Q2 revenue ₹7,615 Cr (+23%), EBITDA ₹1,191 Cr (+29%), margin 15.6% vs 14.9%. Growth is solid, but Apollo Health Co's FY27 margin outlook was trimmed and management avoided explicit hospital growth guidance.
Consolidated Q2 revenue ₹7,615 Cr (+23%), EBITDA ₹1,191 Cr (+29%), margin 15.6% vs 14.9%. Growth is solid, but Apollo Health Co's FY27 margin outlook was trimmed and management avoided explicit hospital growth guidance.
Guides ₹1,500 Cr+ integrated EBITDA for FY27. 1,395 beds: 520 commissioned, remainder in 12-18 months. Demerger targeted for Q4 FY27.
Apollo started FY27 with 21% revenue growth, driven by a 22% surge in Healthcare Services and improved digital health economics.
Apollo Hospitals delivered record FY26 consolidated revenue exceeding ₹25,000 crore, driven by robust performance in its healthcare services and a first-time ₹10,000 crore milestone for Apollo Healthco.
Apollo Hospitals delivered strong FY26 performance with 16% revenue growth and 34% PAT growth. Expansion strategy focuses on adding 2,800+ beds by FY30.
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.